Anisomycin is an antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.
Anisomycin is a naturally occurring antibiotic belonging to the pyrrolidine class, widely recognized for its potent inhibitory effects on protein synthesis in eukaryotic cells. Derived from Streptomyces species, this compound functions primarily by interfering with peptidyl transferase activity on the 60S ribosomal subunit, making it a valuable tool in molecular biology and biochemistry research. Its ability to modulate translational processes has positioned it as a critical reagent for dissecting cellular signaling pathways, gene expression mechanisms, and stress responses. Researchers frequently utilize anisomycin to probe the intricate dynamics of protein biosynthesis and to explore the downstream consequences of translational arrest in various experimental systems.
Protein Synthesis Inhibition: As a robust inhibitor of eukaryotic ribosomal peptidyl transferase, anisomycin is extensively employed to study the mechanisms and regulation of protein synthesis. By selectively blocking translation elongation, it enables researchers to halt de novo protein production, providing a controlled environment to investigate the turnover, stability, and function of pre-existing proteins. This application is particularly valuable in experiments aimed at distinguishing between transcriptional and translational regulatory events, as well as in pulse-chase assays designed to monitor protein degradation rates.
Signal Transduction Research: The compound has become an indispensable tool for elucidating cellular signaling pathways, especially those activated in response to stress. Anisomycin is known to robustly activate stress-activated protein kinases, such as the c-Jun N-terminal kinase (JNK) and p38 MAPK pathways, independent of its effects on translation. This property allows scientists to dissect the molecular cascades triggered by environmental or chemical stressors and to map the upstream and downstream components involved in cellular adaptation, apoptosis, and inflammatory responses.
Gene Expression Studies: By acutely inhibiting translation, anisomycin facilitates detailed investigations into the relationship between mRNA levels and protein output. Researchers utilize it to decouple transcriptional and translational processes, enabling precise analysis of post-transcriptional regulation, mRNA stability, and the kinetics of gene expression changes following various stimuli. Its application in these contexts supports the identification of genes subject to rapid translational control and the characterization of regulatory elements that govern mRNA fate.
Neuroscience Applications: In neurobiology, anisomycin serves as a powerful tool to interrogate the role of protein synthesis in synaptic plasticity, memory consolidation, and neuronal signaling. Its ability to transiently suppress translation in neural tissues has been instrumental in experiments designed to unravel the molecular underpinnings of learning, long-term potentiation, and adaptive responses in the central nervous system. The compound's specificity for eukaryotic ribosomes ensures that its effects are targeted to processes relevant to higher-order cellular functions in neuronal models.
Cellular Stress and Apoptosis Models: The use of anisomycin extends to the development of cellular models for studying stress responses and programmed cell death. By inducing translational arrest and activating stress-responsive kinases, it provides a means to mimic environmental or pharmacological stress in vitro. Researchers leverage these properties to investigate the molecular mechanisms governing apoptosis, autophagy, and cell survival pathways, thereby advancing the understanding of cellular homeostasis and the response to cytotoxic insults.
Anisomycin (2-p-methoxyphenylmethyl-3-acetoxy-4-hydroxypyrrolidine) inhibits protein synthesis in HeLa cells, rabbit reticulocytes, Saccharomyces fragilis, and cell-free extracts prepared from these sources, but it is inactive against extracts of Escherichia coli. Partial inhibition of deoxyribonucleic acid synthesis in HeLa cells is observed at anisomycin concentrations which produce 95% inhibition of protein synthesis. These effects on protein and DNA synthesis are rapid in onset and reversible. Anisomycin acts on the transfer reaction subsequent to the formation of aminoacyl transfer ribonucleic acid. In the presence of anisomycin, nascent peptide remains attached to polyribosomes. No derivative of anisomycin that was tested showed more than 1% of the inhibitory activity of the parent compound.
Inhibitors of Protein Biosynthesis II MODE OF ACTION OF ANISOMYCIN
Anisomycin is an immunosuppressant in low doses with possible application in treatment of some autoimmune diseases and in inhibiting transplantation rejection. Anisomycin suppresses malignant tumor cell growth and affects memory.
Investigation of electrochemical behavior of anisomycin on gold electrode followed by HPLC–MS/MS analysis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More